The Pharmaceutical Journal

The Pharmaceutical Journal is a specialized magazine that focuses on different areas of pharmacy, such as pharmacology and pharmaceutics. It is published by the Royal Pharmaceutical Society, which is the official organization for pharmacists in the UK, previously known as the Royal Pharmaceutical Society of Great Britain.

National, Trade/B2B

English

Journal

Outlet metrics

Domain Authority

Ranking

Global

#195400

United Kingdom

#24838

Health/Pharmacy

#25

Traffic sources

Monthly visitors

Articles

UK’s first safer drug consumption facility accessed more than 2,500 times in first four months, data show

1 week ago | pharmaceutical-journal.com | Katherine Price

The UK’s first safer drug consumption facility (SDCF) in Glasgow has been accessed 2,691 times during the four months it has been open, according to data published by the Glasgow City Health and Social Partnership. According to service data recorded by the SDCF, between January and April 2025, use of the service increased over the first three months — from 336 times in January to 864 times in March 2025 — before dropping slightly to 847 times in April 2025.
NICE to work with NHS Race and Health Observatory to de-bias clinical guidance

1 week ago | pharmaceutical-journal.com | Katherine Price

The NHS Race and Health Observatory and the National Institute for Health and Care Excellence (NICE) have agreed five priority areas for de-biasing clinical guidance.
Almost 80% of pharmacies receive inappropriate antibiotic requests every day, reveals survey

1 week ago | pharmaceutical-journal.com | Antimicrobial resistance |Sasa Jankovic

More than three-quarters (79%) of pharmacies receive requests for unnecessary antibiotics from patients for minor ailments, such as colds, at least once a day, via over-the-counter drugs or during Pharmacy First consultations, a survey conducted by the National Pharmacy Association (NPA) has revealed.
Government commits to introducing pharmacy supervision legislation later in 2025

1 week ago | pharmaceutical-journal.com | Sophie Willis

Pharmacy minister Stephen Kinnock has said that the government will publish the response to its consultation on pharmacy supervision and introduce legislation later in 2025.
Hub-and-spoke dispensing expansion set to begin in October 2025

2 weeks ago | pharmaceutical-journal.com | Katherine Price

Changes to hub-and-spoke dispensing regulations are expected to be permitted from October 2025, government draft legislation has revealed. The government has laid draft amendments to the Human Medicines Regulations 2012 (HMR) in parliament as the next step towards introducing hub-and-spoke dispensing between different legal entities, which the draft legislation said will come into force on 1 October 2025.
Share your experience: tell us about your salary and working conditions

2 weeks ago | pharmaceutical-journal.com | Dawn Connelly

This year, The Pharmaceutical Journal’s Salary and Job Satisfaction Survey contains questions about salary and professional development, as well as a range of issues, including workforce shortages, independent prescribing, designated prescribing practitioners, stress and discrimination. As we do every year, we will use your responses to inform and inspire editorial content that reflects the reality of pharmacy practice.
Community Pharmacy Scotland announces first part of funding deal for 2025/2026

2 weeks ago | pharmaceutical-journal.com | Corrinne Burns

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s offer for the first part of its financial negotiations for community pharmacy in 2025/2026. In a statement, published on 1 May 2025, CPS said that under the offer, which focuses on reimbursement arrangements, the guaranteed minimum for reimbursement will rise to £120m — an increase from £110m in 2024/2025. In 2024/2025, the guaranteed minimum for reimbursement also rose by £10m — from £100m to £110m.
C. difficile cases increase by one-third over three years, government data show

2 weeks ago | pharmaceutical-journal.com | Ellie Philpotts

Clostridioides difficile infections (CDIs) in England have increased by one-third over three years, according to data published by the UK Health Security Agency (UKHSA). In a research and analysis paper, published on 1 May 2025, the UKHSA revealed that CDI cases increased by 33% between the 2020/2021 and 2023/2024 financial years.
Monoclonal antibody ‘critical intervention’ for preventing infant RSV, study suggests

2 weeks ago | pharmaceutical-journal.com | Katherine Price

Monoclonal antibody nirsevimab “provides strong real-world protection” against severe respiratory syncytial virus (RSV) in infants, a meta-analysis has found. The study, published on 1 May 2025 in The Lancet Child and Adolescent Health journal, analysed 27 studies conducted during the 2023/2024 RSV season across five countries: France, Italy, Luxembourg, Spain and the United States.
Chief pharmacists call for medicines leadership to be 'fundamental component' of strategic commissioning system

2 weeks ago | pharmaceutical-journal.com | Ellie Philpotts

Integrated care board (ICB) chief pharmacists across England have written to NHS England, calling for medicines leadership to be a “fundamental component” of an overhauled ICB system. In a joint letter sent on 15 April 2025, four ICB chief pharmacists urged senior NHS England executives to work with pharmacists as strategic commissioning of NHS services in England is developed.